Galena Biopharma Inc


Maxim Lifts Price Target for Galena Biopharma Inc (GALE) Ahead of Two Forthcoming Presentations

Galena Biopharma Inc (NASDAQ:GALE) has announced it will have two post presentations at next week’s San Antonio Breast Cancer Symposium: “VADIS Trial: Phase …

FBR Analyst Adjusts Price Target for Galena Biopharma Inc (GALE) Post Reverse Stock Split

In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), while adjusting …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Presents GALE-301/GALE-302 Phase 1b Data at the Society for Immunotherapy of Cancer Conference 2016

Galena Biopharma Inc (NASDAQ:GALE) committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs, today announced that …

Maxim Bullish on Galena Biopharma Inc (GALE); Excited to See GALE-401 Going to Pivotal Study in 2017

Yesterday, Galena Biopharma Inc (NASDAQ:GALE) released third-quarter earnings and offered a clinical progress update on its pipeline. In reaction, Maxim analyst Jason McCarthy …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Announces 3Q:16 Results and Provides a Corporate Update

Galena Biopharma Inc (NASDAQ:GALE) reported its financial results and provided a corporate update for the quarter ended September 30, 2016. “Over the past …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer

Galena Biopharma Inc (NASDAQ:GALE) announced that Stephen F. Ghiglieri has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective immediately.

Company Update (NASDAQ:GALE): Galena Biopharma Inc Announces Reverse Stock Split

Galena Biopharma Inc (NASDAQ:GALE) announced that on October 26, 2016, the Board of Directors approved a reverse stock split of its shares of common …

Maxim Shines Light on Galena Biopharma Inc (GALE) as Shares Surge 12%

Galena Biopharma Inc (NASDAQ:GALE) shares are climbing almost 12% today after the biotech firm presented data from its Phase 1b trial that evaluates patient’s …

FBR Analyst Comments on Galena Biopharma Inc (GALE) Following Poster Presentation at ESMO

In a research report released yesterday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), with a price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts